Table 9.1 Recommended immunization schedule for children and adolescents aged 18 years or younger (USA, 2017).
Vaccine Birth 1 mo 2 mos4 mos6 mos9 mos 12 mos15 mos18 mos 19–23mos 2–3 yrs4–6 yrs7–10 yrs11–12 yrs 13–15 yrs 16 yrs17–18 yrs
Hepatitis B^1 (HepB) 1 st dose^2 nd dose
Rotaviruseries); RV5 (3-dos^2 (RV) RV1 (2-dosse series)e 1 stdose 2 nd dose
1 stdose 2 nd dose 3 rd dose3 rd dose
3 rd dose4 th dose
4 th dose1 stdose 2 nd dose
1 stdose 2 nd dose2 nd dose
2 nd dose2 nd dose1 stdose1 stdose1 stdose1 stdose2 nd dosefootnote 2Seefootnote 4See4 th dose 5 th dose
Haemophilus influenzae (Hib) type b^43 See footnote 4rd or 4th dose,
Pneumococcal conjugate(PCV13)^5
Inactivated poliovirus(IPV: <18 yrs)^6
Influenza 7 (IIV) Annual vaccination (IIV) 1 or 2 doses Annual vaccination (IIV) 1 dose only
Measles, mumps, rubella^8 (MMR) See footnote 8
Varicella^9 (VAR)
Hepatitis A^10 (HepA) 2-dose series, See footnote10
≥6 weeks; MenACWY-D ≥9 mos;Meningococcal^11 (Hib-MenCY
MenACWY-CRM ≥2 mos) See footnote 11Tetanupertussiss, diphtheria, (^12) (Tdap: & ac≥7 elluyrs)lar Tdap
Human papillomavirus^13 (HPV) See footnote 13
See footnote 11
Pneumococcal polysaccharide(PPSV23)^5 See footnote 5
Range of recommendedages for all children Range of recommended agesfor catch-up immunization Range of recommended agesfor certain high-risk groups Range of recommended ages fornon-high-risk groups that may receive vaccine, subject to
individual clinical decision making No recommendation
3 rd dose
Diphtheria, tetanus, & acellularpertussis (^3) (DTaP: <7 yrs)
Meningococcal B^11
Source: http://pediatrics.aappublications.org/content/133/2/357.